NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY)
$2.16
N/A ( 0% ) 38.4K
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.
Market Data
Open
$2.16
Previous close
$2.16
Volume
38.4K
Market cap
$2.89M
Day range
$2.13 - $2.19
52 week range
$2.05 - $44.80
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 30, 2024 |
8-k | 8K-related | 16 | May 29, 2024 |
10-q | Quarterly Reports | 92 | May 09, 2024 |
8-k | 8K-related | 37 | Apr 22, 2024 |
8-k | 8K-related | 16 | Apr 19, 2024 |
ars | Annual reports | 1 | Apr 18, 2024 |
def | Proxies and info statements | 27 | Apr 18, 2024 |
pre | Proxies and info statements | 28 | Apr 08, 2024 |
10-k/a | Quarterly Reports | 18 | Mar 29, 2024 |
8-k | 8K-related | 14 | Mar 26, 2024 |